Industry › BioTech
Press Releases
Eisai Commences Business Activities At New Pharma Sales Subsidiary In Saudi Arabia
Eisai
Oct 02, 2024 10:28 HKT/SGT
GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis
GEN Pharmaceuticals
Sep 25, 2024 21:00 HKT/SGT
Rozebalamin(R) for Injection 25 mg (Mecobalamin) Approved in Japan for Amyotrophic Lateral Sclerosis
Eisai
Sep 24, 2024 15:06 HKT/SGT
Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management
Ripple Therapeutics
Sep 17, 2024 20:30 HKT/SGT
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies, Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801)
HighTide Therapeutics Inc.
Sep 11, 2024 12:00 HKT/SGT
EASD 2024 | 君圣泰医药口头报告熊去氧胆小檗碱（HTD1801）在T2DM中的两项事后分析
HighTide Therapeutics Inc.
Sep 11, 2024 11:51 HKT/SGT
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies, Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801)
HighTide Therapeutics Inc.
Sep 11, 2024 11:34 HKT/SGT
EASD 2024 | 君聖泰醫藥口頭報告熊去氧膽小檗碱（HTD1801）在T2DM中的兩項事後分析
HighTide Therapeutics Inc.
Sep 11, 2024 11:16 HKT/SGT
Eisai Accelerates Progress in Oncology Research with New Data at ESMO Congress 2024
Eisai
Sep 05, 2024 15:59 HKT/SGT
